Page results
-
BBC News at the NHNN
-
This page tells you about having a Port-a-cath Insertion (implantable port) with the Interventional Radiology team.
-
A lung cancer patient at UCLH is the first to receive a novel cancer vaccine designed to prime the immune system to recognise and fight cancer cells.
-
UCLH has received excellent results in the 2023 National Adult Inpatient Survey this year, with patients rating their overall care 8.8 out of 10. This is an improvement on last year's score of 8.7 and once again makes us the best performing acute/combined trust in England.
-
This page aims to help you decide if a post-dates induction of labour is the right decision for you and your baby.
-
A team of clinician scientists at UCLH have identified the factors which predict full hearing recovery, with the strongest predictor being treatment with steroids within seven days of a sudden drop in hearing.
-
The pancreatobiliary department at UCLH is one of few centres in the UK to provide a patient-centred, comprehensive advanced interventional endoscopy service for diseases of the pancreas and biliary tree.
-
The UCLH children’s FGC/M clinic provides specialist care for children and adolescents who have undergone or are at risk of FGC/M.
-
Information about the integrated cancer care service at the Royal London Hospital for Integrated Medicine.
-
Information about the integrated women's service at the Royal London Hospital for Integrated Medicine
File results
-
FOI/2023/0592 - Procurement staff organisation chart
-
FOI/2023/0374 - Stillbirths, neonatal deaths, maternal deaths at Trust from 2018 - 2022
-
FOI/2023/0376 - Director of Estate and Facilities/ Head of Patient Experience contact details
-
FOI/2023/0379 - MDT meetings in relation to tailgut cysts
-
FOI/2023/0591 - Healthcare Assistants agency rates 2023
-
FOI/2023/0380 - Flexible nurse bank rates/ spend March 2023
-
FOI/2023/0383 - Cataract referrals
-
FOI/2023/0415 - Contact details for senior staff at Estates and Facilities
-
FOI/2023/0422 - Renal cell treatment for carcinoma and melanoma
-
FOI/2023/0416 - Treatments for non-small cell lung cancer